Top Industry News

Bristol Myers Squibb (BMS) and BioNTech, a Mainz-Germany-based bio/pharmaceutical company, have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody, BNT327, across numerous solid…

UCB, a Brussels, Belgium-based bio/pharmaceutical company, has announced plans to build a new US-based biomanufacturing facility and to scale up its partnerships with US-based CDMOs.   The company says that the…

BioNTech, a Mainz, Germany-based bio/pharmaceutical company, has agreed to acquire CureVac, a Tubingen, Germany-based clinical-stage bio/pharmaceutical company specializing in mRNA cancer immunotherapies and vaccines, for $1.25 billion.   With the acquisition,…

The latest from CDMOs, CMOs, and suppliers featuring WuXi Biologics, Euroapi, Simtra BioPharma Solutions, MilliporeSigma, Made Scientific, PharmaLogic, Fujifilm, Antheia, Carbogen Amcis, Cellares, Mitsui, Schott Pharma and DuPont.   Chemicals/Chemical API…

A roundup of bio/pharmaceutical partnering news from Astellas/Evopoint Biosciences, Eli Lilly and Company/Camurus, Novo Nordisk/Deep Apple Therapeutics and Eli Lilly and Company/Juneva.  * Astellas, Evopoint Biosciences in $1.54-Bn ADC Pact *…

A roundup of news from Sanofi, AstraZeneca, the US Government and ADC Therapeutics. Highlights below.   * Sanofi, AstraZeneca Expand RSV Drug Production * HHS Revamps Vaccine Advisory Committee* US DOJ, FTC…

Sanofi has agreed to acquire Blueprint Medicines, a Cambridge, Massachusetts-based bio/pharmaceutical company specializing in rare diseases, in a $9.5-billion deal ($9.1 billion upfront and up to $400 million in milestone…

Zydus Lifesiences, an Ahmedabad, India-based bio/pharmaceutical compay, has agreed to acquire the manufacturing assets of Agenus, a Lexington, Massachusetts bio/pharmaceutical company specializing in immuno-oncology, to form a new biologics CDMO…

The Council of the European Union, composed of the ministers of the European Union’s (EU) 27 member states, took a step forward this week (June 4, 2025) on pharmaceutical policy…

The US Food and Drug Administration (FDA) has launched Elsa, a generative artificial intelligence (AI) tool designed to help employees—from scientific reviewers to investigators—work more efficiently.   “Following a very successful…